n,n-dimethylarginine has been researched along with 2019 Novel Coronavirus Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doğan, Ö; Haşimi, A; Serdar, CC; Serdar, MA | 1 |
| Bassi, F; Böger, R; Cescutti, D; Cifù, A; Curcio, F; Fabris, M; Fapranzi, S; Hannemann, J; Ripoli, A; Sbrana, F; Sozio, E; Sponza, M; Tascini, C; Vetrugno, L | 1 |
| Al-Abdulla, N; Bakhsh, A; Mannocci, F; Moyes, D; Niazi, SA; Proctor, G | 1 |
| Balfanz, P; Böger, R; Dahl, E; Dreher, M; Hannemann, J; Hartmann, B; Marx, N; Müller-Wieland, D; Schwedhelm, E; Ule, J | 1 |
4 other study(ies) available for n,n-dimethylarginine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients.
Topics: Arginine; COVID-19; Disease Progression; Humans; omega-N-Methylarginine | 2023 |
The role of asymmetric dimethylarginine (ADMA) in COVID-19: association with respiratory failure and predictive role for outcome.
Topics: Arginine; Biomarkers; COVID-19; Humans; Respiratory Insufficiency; RNA, Viral; SARS-CoV-2 | 2023 |
Successful endodontic treatment reduces serum levels of cardiovascular disease risk biomarkers-high-sensitivity C-reactive protein, asymmetric dimethylarginine, and matrix metalloprotease-2.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; COVID-19; COVID-19 Vaccines; Glycated Hemoglobin; Humans; Matrix Metalloproteinase 2; Metabolic Syndrome | 2023 |
Elevated serum SDMA and ADMA at hospital admission predict in-hospital mortality of COVID-19 patients.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Cohort Studies; COVID-19; Female; Hospital Mortality; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Risk Factors; SARS-CoV-2 | 2021 |